Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性类均由互联网资源自动生
,
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗药物疗效标志,被用
评估患者危险,在某些
中也用
调整治疗强度。
声明:句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血药物疗效标志,被用
评估患者危险,在某些
例中也用
调整治疗强度。
:
上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病效标志,被用
评估患者危
,
些病例中也用
调整治
强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性分类均由互联自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血药物疗效标志,被用
评估患者危险,在某些
例中也用
调整治疗强度。
:
上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。